суббота, 9 апреля 2016 г.

Here are Credit Suisse's top 3 biotech picks

Here are Credit Suisse's top 3 biotech picks


Celgene : Target $144. Implied upside 33% . "We believe that CELG looks cheap relative to its growth after reviewing current and pipeline products.



from Biotech News